Related Experiment Videos
Renal brush border membrane vesicle aminoglycoside binding and nephrotoxicity
1Department of Pathology, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, USA.
Summary
Aminoglycoside antibiotic binding to kidney membranes shows similarities between rats and humans. However, binding affinity and capacity may not fully predict in vivo kidney toxicity.
Area of Science:
- Pharmacology
- Toxicology
- Nephrology
Background:
- In vitro binding affinity of aminoglycoside (AG) antibiotics to renal brush border membranes (BBM) correlates with in vivo AG nephrotoxicity in rats.
- Previous studies linked variables like sex, age, and antibiotic type to AG nephrotoxicity.
Purpose of the Study:
- To extend the correlation of in vitro binding affinity to in vivo differences in tobramycin sensitivity between rat strains.
- To investigate gender differences in tobramycin nephrotoxicity by comparing BBM binding affinity.
- To compare tobramycin binding characteristics in rat and human renal BBM.
Main Methods:
- Compared in vitro tobramycin binding affinity (KD) and binding capacities in different rat strains and sexes.
- Utilized renal BBM vesicles from rat kidneys and a single human kidney for binding studies.
- Performed Scatchard analyses to characterize binding kinetics and identified binding sites.
- Assessed the effect of polyaspartic acid on tobramycin binding to human BBM vesicles.
Main Results:
- Tobramycin binding affinity (KD) did not correlate with in vivo strain differences in AG nephrotoxicity.
- BBM vesicle tobramycin binding affinity did not correlate with previously reported in vivo gender differences in tobramycin nephrotoxicity.
- Binding capacities correlated with in vivo nephrotoxicity comparisons only between male Sprague-Dawley and male Fischer rats.
- Tobramycin binding to human renal BBM vesicles showed similar rapid, saturable kinetics and low affinity, high capacity characteristics as rat BBM.
- Polyaspartic acid blocked tobramycin binding to human BBM vesicles.
Conclusions:
- Aminoglycoside binding to renal BBM is qualitatively similar in rats and humans.
- Quantitative kinetic aspects like KD and binding capacities may not be critical determinants in the pathogenesis of AG nephrotoxicity.